Keith Regnante
Director of Finance/CFO bei KEROS THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Profil
Keith C.
Regnante is currently the Chief Financial Officer at Keros Therapeutics, Inc. He previously worked as the Senior Director-Corporate Finance at Biogen, Inc. from 1999 to 2013, Head-Research & Development Finance at ARIAD Pharmaceuticals, Inc. from 2013 to 2014, Vice President-Finance at Shire Pharmaceuticals, Inc. from 2014 to 2016, and Chief Financial & Accounting Officer at Wave Life Sciences Ltd.
from 2016 to 2020.
He received his undergraduate degree from Tufts University and his MBA from MIT Sloan School of Management.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
KEROS THERAPEUTICS, INC.
-.--% | 13.02.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Keith Regnante
Unternehmen | Position | Beginn |
---|---|---|
KEROS THERAPEUTICS, INC. | Director of Finance/CFO | 01.02.2020 |
Ehemalige bekannte Positionen von Keith Regnante
Unternehmen | Position | Ende |
---|---|---|
WAVE LIFE SCIENCES LTD. | Director of Finance/CFO | 09.01.2020 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01.08.2016 |
ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.02.2014 |
BIOGEN INC. | Public Communications Contact | 01.08.2013 |
Ausbildung von Keith Regnante
Tufts University | Undergraduate Degree |
MIT Sloan School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BIOGEN INC. | Health Technology |
WAVE LIFE SCIENCES LTD. | Health Technology |
KEROS THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |